GIUFFRE RANDALL MICHAEL received a stock award from DIAMEDICA THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001759822-26-000002
Director
Since Dec 2018
+6.17K
Net shares
Net buyer
$52.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.17K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.17K
Price / share
$8.42
Trade value
$51.99K
% of position
1.6%
1/2/2026
392.41K→398.59K
Total
Net shares
+6.17K
Net value
$51.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +6.17K | $8.42 | $51.99K | 1.6% | 392.41K | 398.59K |
| Total | +6.17K | $51.99K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned25.57K
Common Stock
IndirectShares owned21.07K
Total
46.64K indirect46.64K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.57K | Indirect |
| Common Stock | 21.07K | Indirect |
| Total | 46.64K | 46.64K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported